Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
Clinical trial NCT02833350 · COMPLETED
Trial details
- NCT number
- NCT02833350
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-09
- Primary completion
- 2018-07-02
- Enrollment
- 578
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.